| |
Joseph C. Cappelleri |
Ph.D., M.P.H., M.S.
Office:
Pfizer Inc, Global Research & Development, MS 6025-A4225, 50 Pequot Ave, New London, CT 06320
Tel: (860) 732-8668 Fax: (860) 715-7879
Email: joseph.c.cappelleri@pfizer.com |
Education
Graduate
1993: M.P.H. (Epidemiology), Harvard University, Cambridge, MA (GPA=3.9)
1991: Ph.D. (Psychometrics), Cornell University, Ithaca, NY (GPA=4.0)
1986: M.S. (Statistics), City University of New York (Baruch College), NY (GPA=3.8)
Undergraduate
1984: B.B.A. (Finance), City University of New York (Baruch College), NY (GPA=3.8)
Work Experienceork
08/2008 - present
01/2004 - 07/2008
12/2002 - 12/2003
02/2000 - 11/2002
02/1998 - 01/2000
06/1996 - 01/1998
11/2007 - present
08/2003 - 09/2007
09/2007 - present
10/1996 - 09/2007
03/1993 - 06/1996
02/1992 - 09/1992
01/1990 - 09/1991 |
Pfizer Inc, Global Research & Development, New London, CT
Senior Director, Statistical Scientist, Biostatistics
Director, Statistical Scientist, Biostatistics
Senior Associate Director, Statistical Scientist, Biostatistics
Associate Director II, Biostatistics
Associate Director I, Biostatistics
Senior Coordinator, Biostatistics
Provide statistical and methodological consulting and advising - manuscripts, presentations, design & analysis, internal reports, analysis plans, teaching and moderating workshops, collaborations with clinicians & biostatisticians - across therapeutic areas and phases of drug development in health services and outcomes research
Adjunct Professor of Statistics
Adjunct Associate Professor of Statistics
Department of Statistics, University of Connecticut, Storrs, CT
Teach semester-long graduate courses on epidemiology and longitudinal analysis as well as supervise students and collaborate with students
Adjunct Professor of Medicine
Adjunct Associate Professor of Medicine
Department of Medicine, Division of Clinical Care Research, Tufts Medical School, Boston, MA
Collaborate with faculty, supervise students, and lecture
Research Associate and Assistant Professor of Medicine
New England Medical Center and Tufts University School of Medicine, Department of Medicine, Division of Clinical Care Research, Boston, MA
Involved with the development and management of the Real-Time Meta- Analysis System - a systematic approach and computer software to organize, display, and utilize data from randomized control trials to perform meta-analysis efficiently - for pharmaceuticals agents that cover antibiotic usage, hypertension, congestive heart failure, and AIDS
Involved with meta-analyses to evaluate the efficacy and safety of drugs that cover infectious (including AIDS), cardiovascular, and cerebrovascular diseases
Involved with statistical and methodological issues in meta-analysis
Presented lectures on meta-analysis to post-doctoral fellows
Research Associate, Technology Assessment Group, Harvard School of Public Health, Boston, MA
Prepared a meta-analysis on the relative efficacy and safety of different aspirin dosages on vascular events
Research Support Specialist, National Data Archive on Child Abuse & Neglect, Cornell University, Ithaca, NY
Provided statistical and technical support on the Second National Incidence and Prevalence Study of Child Abuse & Neglect
Worked with complex survey data analyzed with the programs WESVAR WESREG, and WESLOG; used large data tapes, SAS, and the VM/MVS and VM/CMS computer operating system |
Awards, Honors and Recognition
2009
2009
2009
2009
2009
2008
2008
2008
2008
2008
2007
2007
2007
2007
2007
2007
2007
2006
2006
2006
2005
2005
2005
2005
2005
2004
2004
2004
2003
2003
2002
2001
2001
2001
2001
2001
2001
1995
1991
1990
1986
1984
1984
1983 |
Elected to Think Science Now 100, a group that includes 100 of Pfizer's most inspiring science and medical professionals, and authorized to serve as a Science Ambassador for Pfizer.
Earned Individual Performance Award for bringing new insights into the clinical relevance of Peak VO2 (oxygen consumption) as an endpoint in children with pulmonary arterial disease –exemplary leadership on the development, execution, analysis, and finalization on the Peak VO2 validation—that attests to Pfizer’s ability to move science forward beyond its own assets.
Earned Individual Performance Award for exceptional performance and leader behaviors on a daily basis in support of Celebrex.
Earned Individual Performance Award for demonstrating the Pfizer values of innovation, quality, teamwork with publications in 2008: "Your ability to work together with many colleagues exemplifies leadership and focus on customers."
Identified as a top reviewer (based on influence and quality of reviews) for Quality of Life Research in 2008
Recognized for scholarship on communication strategies for patients with erectile dysfunction: article featured as part of continuing medical education credit in newsletter Primary Issue (volume 10, issue 3, 2008)
Selected as an outstanding reviewer for Quality of Life Research, 2007
Nominated for both the W.E. Upjohn award and the Pfizer Achievement Award
Recognized for coauthoring among the most influential Pfizer publications for excellence in clinical sciences (Journal of Sexual Medicine 2007; 4:1626-1634)
Certified Concepts Systems Facilitator
Scored highest in performance (perfect score) among statisticians at Pfizer
Chosen as a lecturer in the Pfizer-sponsored Brown University Science Ambassador Program
Shared with team members the Prix Galien prize for Best Pharmaceutical Agent for Chantix/Champtix for smoking cessation
(this prize is often referred to as the Nobel Prize for the pharmaceutical industry)
Coauthored article (Allison et al. American Journal of Psychiatry. 1999; 156:1686-1696) ranked as the sixth most cited article ever in the American Journal of Psychiatry
Exceptional psychometric validation on patient-reported outcomes (including the Erection Hardness Scale) in erectile dysfunction (Pfizer Inc)
Outstanding psychometric validation on patient-reported outcomes in obesity (Pfizer Inc)
Interviewed in Doctor’s Guide to the Internet article "Sunitinib (Sutent) Improves Quality of Life over Interferon-Alfa in Kidney Cancer" based on conference presentation.
Interviewed in Pfizer Press Release on "New Data Suggest Pfizer’s Varenicline Reduces Craving and Withdrawal Symptoms Associated with Quitting Smoking and Decreases Satisfaction and Reward from Smoking" for delivering conference presentations
Interviewed in Blackwell Publishing Press Release on "Erection Pill Associated with Normalization of Relationships and Self-Esteem in Men with Erectile Dysfunction" as lead author on journal article
Leadership, support, and leadership for the Hierarchical and Survival Models Workshops at Pfizer Inc
Research Fellow, Center for Healthcare & Insurance Studies, University of Connecticut, Storrs, CT
Coauthored article (Rosenstock et al. Diabetes Care. 2004; 27:1318-1323)
selected for the Yearbook of Endocrinology 2005 that brings together abstracts of articles that reported the year's breakthrough developments in endocrinology (In: Mazzaferri EL, ed. Yearbook of Endocrinology 2005. Philadelphia, PA: Elsevier)
Leadership, support, and teamwork for the Applied Longitudinal Analysis Workshops at Pfizer Inc
Leadership and team building for presenting 5-hour workshop on meta-analysis to Outcomes Research Group at Pfizer Inc
Statistical and methodological contributions in developing and validating an instrument for early onset for patients with generalized anxiety disorder (Pfizer Inc)
Leadership in and teaching of Item Response Theory Seminar Series to colleagues in Outcomes Research at Pfizer Inc
Regulatory support of Femhrt (Pfizer Inc)
Analysis and strategy in support of Celebrex (Pfizer Inc)
Tireless efforts, enthusiasm, and productive collaborations in support of Outcomes Research at Pfizer Inc
Psychometric analyses of data on smoking cessation (Pfizer Inc)
Leadership, teamwork, and contributions to support Femhrt skin aging program and Zoloft (Pfizer Inc)
Interviewed in book "Viagra: The remarkable story of the discovery and launch" (by Larry Katzenstein, New York: Medical Information Press, 61-62)
Outstanding performance in teaching Modern Psychometric Workshop and Clinical Significance Workshop (Pfizer Inc)
Excellence in overall statistical support to Outcomes Research (Pfizer Inc)
Teamwork and leadership in support of Biometrics support to Ann Arbor’s Outcomes Research development (Pfizer Inc)
Major contributions to inhaled insulin program: Phase 2 (Pfizer Inc)
Major contributions to inhaled insulin program: Phase 3 (Pfizer Inc)
Special and Scientific Staff, Tufts University
Cancer Epidemiology Fellowship, Harvard University
Phi Kappa Phi, Cornell University Chapter
Rosenkranz-Goldstein Award for Excellence in Statistics
Magna Cum Laude
Baruch Alumni Scholarship
Beta Gamma Sigma |
Professional Affiliations
Toastmasters (Thames River)
International Society for Quality of Life Research
Pharmaceutical Research and Manufacturers of America
American Statistical Association
Drug Information Association
International Society for Pharmacoeconomics and Outcomes Research
International Chinese Statistical Association
Society for Clinical Trials
Society for Medical Decision Making
Subjects Taught
Instructor on graduate statistics course "Applied Longitudinal Analysis" to students at the University of Connecticut, Storrs (spring 2006 semester, January 17 – April 28); spring 2008 semester, January 22 - May 2) Instructor on graduate statistics course "Introduction to Epidemiology" to students at the University of Connecticut, Storrs (spring 2004 semester, January 20 – April 30; spring 2005 semester, January 18 - April 29; spring 2007 semester, January 16 – April 27) Instructor on "An Overview of Outcomes Research" and "An Overview of the International Index of Erectile Function" in a managerial statistics seminar at Rensselaer Polytechnic Institute (three-hour lecture, Groton, Connecticut, November 7, 2003) Instructor on "Applying the Rasch Model" (seminar to Pfizer employees, Groton, CT, January - June 2003) Instructor on "Meta-Analysis and Systemic Literature Review - Introduction" (four-hour short course at the Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: Arlington, Virginia, May 20-23, 2001; May 19-22, 2002; May 18-21, 2003; May 16-19, 2004; Washington, DC, May 15-18, 2005. Pfizer Inc, New London, CT, May 21-22, 2003 and June 22, 2004, Pfizer Inc, New York, NY, March 29, 2005) Instructor on "Introduction to Meta-Analysis" in clinical trials course at the University of Connecticut, Storrs (two 3-hour lectures, April 16 and 23, 2003; 3-hour lecture, November 15, 2004) Instructor on "Sample Size Estimation in Outcomes Research" (four-hour short course to Pfizer employees in Ann Arbor, MI, October 17, 2001; Groton/New London, CT, May 15, June 21, 2003) Instructor on "Introduction to Business Statistics" (spring 1987 and summer 1987 to Baruch undergraduates) Teaching assistant on "Measurement in Program Evaluation & Research" (fall 1988 to Cornell graduate students) Teaching assistant on "Program Evaluation & Research Design" (spring 1989 to Cornell graduate students) Teaching assistant on "Statistics and the World We Live In" (spring 1988 to Cornell undergraduate)
Former Research Support
Contract: University of Illinois at Chicago, National Research and Training Center on Psychiatric Disability
Amount: $53,000
Period: 9/1995 - 6/1996
Role: Statistical Consultant
Grant Title: Comparative Outcomes of Ambulatory Pharmaceutical Agents
Funding Agency: Agency for Health Care Policy and Research
Amount: $1.2 million
Period: 3/1993 - 3/1996
Role: Co-Investigator
Bibliography (.doc)
|
